# Transcranial magnetic stimulation therapy for central post-stroke pain: systematic review and meta-analysis

## TL;DR

This study reviews and analyzes the effectiveness of rTMS in reducing central post-stroke pain, finding some evidence of benefit.

## Contribution

A systematic review and meta-analysis of rTMS for central post-stroke pain, providing a synthesis of current evidence.

## Key findings

- rTMS showed a significant reduction in central post-stroke pain compared to sham.
- The effect size was large, but the evidence quality was low.
- Six studies with 180 participants were included in the quantitative analysis.

## Abstract

Although rare, central post-stroke pain remains one of the most refractory forms of neuropathic pain. It has been reported that repetitive transcranial magnetic stimulation (rTMS) may be effective in these cases of pain.

The aim of this study was to investigate the efficacy of rTMS in patients with central post-stroke pain (CPSP).

We included randomized controlled trials or Controlled Trials published until October 3rd, 2022, which studied the effect of rTMS compared to placebo in CPSP. We included studies of adult patients (>18 years) with a clinical diagnosis of stroke, in which the intervention consisted of the application of rTMS to treat CSP.

Nine studies were included in the qualitative analysis; 6 studies (4 RCT and 2 non-RCT), with 180 participants, were included in the quantitative analysis. A significant reduction in CPSP was found in favor of rTMS compared with sham, with a large effect size (SMD: −1.45; 95% CI: −1.87; −1.03; p < 0.001; I2: 58%).

The findings of the present systematic review with meta-analysis suggest that there is low quality evidence for the effectiveness of rTMS in reducing CPSP.

Identifier (CRD42022365655).